 
							Moderna, Inc., a US based biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, has announced...
 
							Prestige Biopharma Limited (PBP), based in Singapore, has announced that the company will be introducing a vaccine devel...
 
							The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces that Drug Controller General o...
 
							Novavax Inc, GlaxoSmithKline (GSK) and the UK Government Vaccines Taskforce have reached an agreement i...
 
							Sanofi has announced a €400 million investment over five years to create a unique vaccine production center in Sing...
 
							Germany based CureVac N.V., a biopharmaceutical company developing a new class of transformative medicines based on mess...
 
							The Therapeutic Goods Administration (TGA) in Australia has recently approved wider storage and transportation condition...
 
							The International Vaccine Institute (IVI) and the Institut Pasteur Korea (IPK) have signed a memorandum of understanding...
 
							China based CanSino Biologics Inc. has announced that the Instituto de Salud Pública de ...
 
							South Korea’s Food and Drug Safety Ministry has granted final approval for the use of Johnson & Johnson’...
 
							Tumor vaccines can help the body fight cancer. Mutations in the tumor genome often lead to protein changes that are typi...
 
							The HOPE Consortium’s World Immunisation & Logistics Summit opened on March 30, 2021 by H.H. Sheikh Abdul...
 
							Takeda Pharmaceutical Company Limited has announced that the European Medicines Agency (EMA) has accepted the compa...
 
							Positive high-level results from the primary analysis of the Phase III trial of AZD1222 in the US have confirmed vaccine...
 
							The Board of Gavi, the Vaccine Alliance on March 23, 2021, has approved the COVAX Buffer to ensure access to C...
 
							CanSinoBIO Biologics Inc. announced that the Hungarian National Institute of Pharmacy and Nutrition (OGYÉI) grant...
 
							Daiichi Sankyo Company, Limited has announced that it has started the first vaccinations in a phase 1/2 clinical trial i...
 
							The Therapeutic Goods Administration (TGA) has approved manufacture of the AstraZeneca COVID-19 Vaccine (ChAdOx1-S) in A...
 
									 
									 
									